Codes / ICD10CM / M05.079

M05.079 Felty's syndrome, unspecified ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Felty's syndrome, unspecified ankle and foot

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). When affecting the ankle and foot, it involves chronic inflammation of these joints alongside systemic manifestations. The condition typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA). Ankle and foot involvement occurs as part of the broader rheumatoid arthritis process affecting multiple joints.

Risk Factors

  • Long-standing, severe rheumatoid arthritis
  • High titers of rheumatoid factor
  • Presence of anti-citrullinated protein antibodies (ACPA)
  • Advanced age (typically over 50 years)
  • Female gender (more commonly affected)

Symptoms

  • Persistent joint pain, swelling, and stiffness in the ankle and foot
  • Fatigue and weakness
  • Recurrent infections due to neutropenia
  • Abdominal discomfort or fullness from splenomegaly
  • Unexplained weight loss
  • Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome, unspecified ankle and foot, requires confirmation of the triad of rheumatoid arthritis, splenomegaly, and neutropenia, along with clinical evaluation of ankle and foot involvement. Laboratory tests include complete blood count (CBC) to assess neutrophil levels, rheumatoid factor, and anti-citrullinated protein antibodies. Imaging studies, such as X-rays or MRI, may be used to evaluate joint damage in the ankle and foot. Splenomegaly is typically confirmed via physical examination or imaging (e.g., ultrasound).

Treatment Options

Treatment focuses on managing rheumatoid arthritis and its complications. Disease-modifying antirheumatic drugs (DMARDs) are used to control joint inflammation. Granulocyte colony-stimulating factor (G-CSF) may be prescribed to address neutropenia and reduce infection risk. Splenectomy is rarely considered and reserved for severe cases. Pain management and physical therapy may help alleviate ankle and foot symptoms.

Prognosis and Follow-Up

Prognosis depends on the severity of rheumatoid arthritis, neutropenia, and infection risk. With appropriate treatment, joint symptoms and systemic manifestations can be managed, but long-term monitoring is essential. Regular follow-up includes blood tests to monitor neutrophil counts and joint assessments to track disease progression.

Complications

  • Increased susceptibility to severe infections due to neutropenia
  • Progressive joint damage in the ankle and foot
  • Splenic rupture (rare)
  • Anemia or other blood cell abnormalities
  • Reduced quality of life from chronic pain and fatigue

Lifestyle & Prevention

  • Maintain regular medical care to manage rheumatoid arthritis
  • Practice good hygiene to reduce infection risk
  • Engage in gentle exercise to preserve joint function
  • Avoid smoking, which may worsen rheumatoid arthritis
  • Follow a balanced diet to support overall health

When to Seek Professional Help

Seek immediate medical attention if you experience:

  • Signs of infection (e.g., fever, chills, persistent sore throat)
  • Severe joint pain or swelling in the ankle or foot
  • Unexplained weight loss or fatigue
  • Abdominal pain or rapid enlargement of the spleen

Tips for Medical Coders

When coding Felty's syndrome, unspecified ankle and foot (M05.079), ensure documentation supports the triad of rheumatoid arthritis, splenomegaly, and neutropenia, along with ankle and foot involvement. Verify that the condition is not specified as left or right, as this code is for unspecified sites. Document clinical findings, lab results, and treatment plans to support accurate coding and billing.

Book a walkthrough

M05.079 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.